National Comprehensive Cancer Network



NCCN Oncology Research Program (ORP)
NCCN Volasertib Research Grant Opportunity – Submit by October 30, 2014
NCCN ORP Recent News
NCCN ORP Affiliate Research Consortium
NCCN ORP Scientific Publications
NCCN ORP for Industry
NCCN ORP Investigator Steering Committee
NCCN ORP Testimonials
NCCN Clinical Trials at NCCN Member Institutions
Find NCCN ORP Funded Clinical Trials at NCCN Member Institutions
NCCN ORP Grant History
NCCN Informed Consent Language Database
NCCN Specialized Imaging Research Consortium™ (SIRC)
NCCN ORP Disclosure Policy
NCCN Collaboration with the National Business Group on Health
NCCN Health Information Technology Licensees

NCCN Research & Business Resources


Duke Cancer Institute
Durham, North Carolina
888.275.3853 (888.ASK.DUKE)
dukecancerinstitute.org

Pediatric Oncology Services

Introduction

Pediatric oncology specialists at Duke offer children, adolescents, and young adults the most advanced and individualized cancer therapies available—many of which were developed through Duke's participation in the National Cancer Institute (NCI)-supported Children's Oncology Group, a global research collaboration.

Our physicians see more than 100 newly diagnosed patients every year, evaluating and treating cancers that include acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML); Hodgkin and non-Hodgkin lymphoma; neuroblastoma; Wilms tumor; retinoblastoma; Ewing sarcoma, osteosarcoma, and other soft-tissue sarcomas; hepatoblastoma; brain and spinal-cord tumors;Langerhans cell histiocytosis, and germ-cell tumors. Many have special expertise in treating neuroblastoma, rhabdomyosarcoma, leukemia, and brain tumors.

Special Expertise

Special expertise is available in:

  • Blood and Marrow Transplant
  • Therapy for Neuroblastoma
  • Treatment of Pediatric Brain Tumors
  • Sarcoma Therapy in Children, Adolescents, and Young Adults
  • Multidisciplinary clinic for long-term survivors of childhood and young adult cancer

The largest of its kind in the world, Duke's Pediatric Blood and Marrow Transplant (PBMT) Program now transplants some 100 children annually. Our highly specialized clinicians have cared for and supported more than 1,800 children and their families since the program was established in 1990—more than half of whom are still alive and considered cured of their underlying diseases.


General Information

General Information

888.ASK.DUKE (888.275.3853)

Referring Physician Line

800.MED.DUKE (800.633.3853)

Location

The Duke Children's Hospital & Health Center are located on Erwin Road in Durham, NC.

Travel assistance

Social workers and patient resource managers provide assistance in locating transportation resources. They will also help families to locate financial assistance for transportation

Lodging

The Ronald McDonald House is located less than one mile from Duke Children's Hospital. The first reservation must be made by a social worker or patient resource manager. There is van service available. The address is:

The Ronald McDonald House of Durham

506 Alexander Avenue

Durham, NC 27705

Telephone: 919.286.9305

www.ronaldhousedurham.org

There are several hotels (some within walking distance) with special medical rates. Social workers help families to locate financial assistance for lodging that is required by medical treatment.

Social Support

Psychosocial support services are tailored to each family's needs. Each family meets with a primary social worker who provides support throughout treatment. In addition, psychologists, child life specialists, and chaplains are available. Duke has a hospital school for preschool through 12th grade.

Home Health Care

Our outpatient and inpatient home care planning teams coordinate home health care services throughout North Carolina and the adjacent states in which our patients live.

Ages Treated

Birth through age 35


Clinical and Research Information

Program Chairman

Daniel S. Wechsler, MD, PhD

Operate Multidisciplinary Teams

Patients have available a multidisciplinary team of physicians, nurses, nurse practitioners, physician assistants and other health care professionals who specialize in treating the pediatric patient population. Patients with sarcomas and brain tumors are cared for by specialized multidisciplinary teams comprised of surgeons, pediatric oncologists, radiation oncologists, pathologists, radiologists, and physical therapists. Tumor boards are held on a regular basis and clinical case conferences are held weekly. Psychosocial rounds are also a regular feature of the conference schedule. Twice weekly didactic conferences are a major part of our formal course work for fellow trainees and are open to all.

Cooperative Group Membership

Children's Oncology Group, Pediatric Brain Tumor Consortium

Activities in Cooperative Group

Members of the Division serve in major leadership roles on a number of different disease and discipline committees in the Children's Oncology Group and the Pediatric Brain Tumor Consortium.

Average Number of Pediatric Clinical Trials

65

Research Efforts

Both clinical and basic research is ongoing in the areas of molecular biology of rhabdomyosarcoma, neuroblastoma, acute myeloid leukemia, and hematopoietic transplantation biology. The program fully participates in clinical research trials within the Children's Oncology Group.

Special Expertise

Special expertise is available in bone marrow transplantation, neuroblastoma, adolescent and young adult sarcoma, and brain tumors. There is also a multidisciplinary clinic for long-term survivors of childhood cancer.

Statistics

Percent of children treated in each age range

Age Range

0-1

2-5

6-12

13+

Percent Treated

10%

25%

30%

35%


Pediatric Hematology-Oncology, Neuro-Oncology and Transplant Programs, 2008-9

No. of Inpatient Beds

No. of Admissions

Average Length of Stay (days)

No. of New Outpatients

Total Outpatient Visits

No. of Bone Marrow Transplants

No. of Oncologists

31 Intermediate Care;
16 Transplant

797

5.9 Excluding BMT

593

12,267

74

13 oncologists and 7 pediatric BMT physicians.